NEULAND LABORATORIES LTD. - 524558 - Board Meeting Intimation for Considering And Approving The Audited Financial Results For The Quarter And Year Ended March 31, 2021 And To Recommend Final Dividend For FY 2020-21, If Any
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2021 ,inter alia, to consider and approve a. the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2021. b. the recommendation of final dividend, if any, for the financial year ended March 31, 2021.27-04-2021